Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-12,453
Closed -$863K 192
2022
Q2
$863K Sell
12,453
-5,543
-31% -$411K 0.25% 108
2022
Q1
$1.38M Sell
17,996
-138
-0.8% -$9.92K 0.27% 105
2021
Q4
$1.39M Buy
18,134
+408
+2% +$30K 0.29% 105
2021
Q3
$1.31M Buy
17,726
+225
+1% +$16.9K 0.27% 107
2021
Q2
$1.17M Buy
17,501
+5,087
+41% +$340K 0.24% 114
2021
Q1
$923K Buy
12,414
+904
+8% +$68.6K 0.22% 113
2020
Q4
$838K Buy
11,510
+76
+0.7% +$5.37K 0.22% 120
2020
Q3
$766K Buy
11,434
+375
+3% +$23.7K 0.22% 117
2020
Q2
$630K Buy
11,059
+1,152
+12% +$56.5K 0.22% 131
2020
Q1
$490K Sell
9,907
-7,121
-42% -$339K 0.21% 137
2019
Q4
$889K Buy
+17,028
New +$848K 0.31% 129

Other funds holding HOLX

Hohimer Wealth Management's HOLX Position: Q3 2022 in Review

Hohimer Wealth Management sold out of Hologic (HOLX) in Q3 2022, closing a stake of 12,453 shares — an estimated $863K sold.

Hohimer Wealth Management first reported a position in HOLX in Q4 2019 and held it in 11 quarters. The position peaked at $1.39M in Q4 2021. 654 funds tracked by Wall St. Rank hold HOLX as of Q3 2022.

  • Hohimer Wealth Management reported no remaining Hologic position as of Q3 2022 after selling out during the quarter.
  • Hohimer Wealth Management sold 12,453 Hologic shares in Q3 2022, an estimated $863K.
  • Hohimer Wealth Management first reported a position in Hologic in Q4 2019 and held it in 11 quarters.
  • Hohimer Wealth Management's Hologic position peaked at $1.39M in Q4 2021.
  • 654 funds tracked by Wall St. Rank held Hologic as of Q3 2022.

Based on Hohimer Wealth Management's 13F filing for Q3 2022, filed 2 Nov 2022.